Tips on Finding Insurance Coverage for Cancer Rehabilitation
July 02, 2012 – Kathy LaTour
Recognizing Actinic Keratosis
June 19, 2012 – Jon Garinn
Two Congressional Bills on Colorectal Cancer Introduced
June 19, 2012 – Lena Huang
We Do Harm: A Doctor Breaks Ranks About Being Sick in America
June 15, 2012 – Katherine Lagomarsino
Finalist Esssay: Not Just a Nurse, But Also an Angel
June 15, 2012 – Cesar Quesada
Finalist Essay: My Christmas Carol
June 14, 2012 – Wendy Crowther
Long-Term Estrogen-Only Hormone Therapy Increases Breast Cancer Risk
June 13, 2012 – Elizabeth Whittington
Breast Cancer Call to Rehabilitation & Exercise Action
June 16, 2012 – Kathy LaTour
Is Rehabilitation Right for You?
June 16, 2012 – Kathy LaTour
Prevention is the Best Medicine When It Comes to HPV
June 16, 2012 – Charlotte Huff
First Steps: Vaccine Research
June 15, 2012 – Elizabeth Whittington
Myths About the Dying Process
June 16, 2012
Expressing Oneís Thoughts
June 16, 2012 – Katy Human
Rx-Fueled Anger
June 15, 2012 – Heather L. Van Epps, PhD
Questions to Ask About a Clinical Trial
June 16, 2012 – Paul Engstrom
Better, Stronger, Happier
June 16, 2012 – Carole Schneider, PhD
Pipeline
June 13, 2012 – Lindsay Ray
My Oncology Angel
June 14, 2012 – Greg Schilling
Sweet Relief: Could Chocolate Prevent Cancer?
June 14, 2012 – Melissa Gaskill
EPA Plans to Cut Radon Program, Despite Continued Cancer Risk
June 16, 2012 – Jane Hill
Light Bright: Awareness of Skin Sensitivity
June 12, 2012 – Lacey Meyer
Shifts in Causation, Biology and Treatment of Head and Neck Cancer
June 13, 2012 – Debu Tripathy, MD
Comments from our Readers
June 14, 2012
Cruciferous Veggies May Ward Off Recurrence
June 15, 2012 – Kathy LaTour
Q&A: Counterfeit Chemotherapy Drugs Cause Concern
June 16, 2012 – Len Lichtenfeld, MD
CT Challenge Survivorship Summit
June 16, 2012 – Jon Garinn
Swift Thanks Absentee Date at ACM Awards
June 15, 2012 – Lindsay Ray
Leukemia Survival Rates Greatly Improved, Study Says
June 16, 2012 – Katherine Lagomarsino
ASCO Updates
June 12, 2012 – Staff Reports
Letting Go: Saying Goodbye When a Loved One Says Itís Time
June 13, 2012 – Don Vaughan
The Write Stuff: Expressive Writing About Cancer Promotes Healing and Well-Being
June 11, 2012 – Katy Human
Seeing Red: Coping with Anger During Cancer
June 10, 2012 – Heather L. Van Epps, PhD
Trials & Tribulations: Pursuing a Clinical Trial Requires Determination and Education
June 11, 2012 – Paul Engstrom
Road to Recovery: Cancer Rehab Defines the New Normal
June 10, 2012 – Kathy LaTour
Facing the Facts: HPV-Associated Head and Neck Cancers Get a Second Look
June 15, 2012 – Charlotte Huff
Calling Cancer's Bluff: Research in Vaccine Therapy for Cancer Is Paying Off
June 11, 2012 – Laura Beil
Tips on Finding Insurance Coverage for Cancer Rehabilitation
July 02, 2012 – Kathy LaTour
Recognizing Actinic Keratosis
June 19, 2012 – Jon Garinn
Two Congressional Bills on Colorectal Cancer Introduced
June 19, 2012 – Lena Huang
We Do Harm: A Doctor Breaks Ranks About Being Sick in America
June 15, 2012 – Katherine Lagomarsino
Finalist Esssay: Not Just a Nurse, But Also an Angel
June 15, 2012 – Cesar Quesada
Finalist Essay: My Christmas Carol
June 14, 2012 – Wendy Crowther
Currently Viewing
Long-Term Estrogen-Only Hormone Therapy Increases Breast Cancer Risk
June 13, 2012 – Elizabeth Whittington
Is Rehabilitation Right for You?
June 16, 2012 – Kathy LaTour
Prevention is the Best Medicine When It Comes to HPV
June 16, 2012 – Charlotte Huff
First Steps: Vaccine Research
June 15, 2012 – Elizabeth Whittington
Myths About the Dying Process
June 16, 2012
Expressing Oneís Thoughts
June 16, 2012 – Katy Human
Rx-Fueled Anger
June 15, 2012 – Heather L. Van Epps, PhD
Questions to Ask About a Clinical Trial
June 16, 2012 – Paul Engstrom
Better, Stronger, Happier
June 16, 2012 – Carole Schneider, PhD
Pipeline
June 13, 2012 – Lindsay Ray
My Oncology Angel
June 14, 2012 – Greg Schilling
Sweet Relief: Could Chocolate Prevent Cancer?
June 14, 2012 – Melissa Gaskill
EPA Plans to Cut Radon Program, Despite Continued Cancer Risk
June 16, 2012 – Jane Hill
Light Bright: Awareness of Skin Sensitivity
June 12, 2012 – Lacey Meyer
Shifts in Causation, Biology and Treatment of Head and Neck Cancer
June 13, 2012 – Debu Tripathy, MD
Comments from our Readers
June 14, 2012
Cruciferous Veggies May Ward Off Recurrence
June 15, 2012 – Kathy LaTour
Q&A: Counterfeit Chemotherapy Drugs Cause Concern
June 16, 2012 – Len Lichtenfeld, MD
CT Challenge Survivorship Summit
June 16, 2012 – Jon Garinn
Swift Thanks Absentee Date at ACM Awards
June 15, 2012 – Lindsay Ray
Leukemia Survival Rates Greatly Improved, Study Says
June 16, 2012 – Katherine Lagomarsino
ASCO Updates
June 12, 2012 – Staff Reports
Letting Go: Saying Goodbye When a Loved One Says Itís Time
June 13, 2012 – Don Vaughan
The Write Stuff: Expressive Writing About Cancer Promotes Healing and Well-Being
June 11, 2012 – Katy Human
Seeing Red: Coping with Anger During Cancer
June 10, 2012 – Heather L. Van Epps, PhD
Trials & Tribulations: Pursuing a Clinical Trial Requires Determination and Education
June 11, 2012 – Paul Engstrom
Road to Recovery: Cancer Rehab Defines the New Normal
June 10, 2012 – Kathy LaTour
Facing the Facts: HPV-Associated Head and Neck Cancers Get a Second Look
June 15, 2012 – Charlotte Huff
Calling Cancer's Bluff: Research in Vaccine Therapy for Cancer Is Paying Off
June 11, 2012 – Laura Beil

Long-Term Estrogen-Only Hormone Therapy Increases Breast Cancer Risk

Estrogen-only hormone therapy ups breast cancer risk if taken long term.

BY Elizabeth Whittington
PUBLISHED June 13, 2012

A new long-term analysis shows that estrogen-only hormone therapy used for more than 10 years increases the risk for breast cancer.

In 2002, a Women’s Health Initiative (WHI) study was stopped early when estrogen plus progestin hormone therapy was shown to increase the risk of invasive breast cancer in healthy postmenopausal women. Later analysis shows the risk of dying from breast cancer also increased.

Because estrogen-only therapy can increase the risk of endometrial cancer, the hormone progestin is added to reduce this risk. In women who have had hysterectomies, estrogen-only hormone therapy is used.

While initial results in another WHI study showed estrogen-only therapy to be safe in regards to breast cancer, a new analysis from the Nurses’ Health Study looked at postmenopausal women who took estrogen-only therapy for longer than 10 years.

Data presented at the American Association for Cancer Research annual meeting showed that women who had used estrogen-only hormone therapy for 10 to about 15 years had a 22 percent increased risk of breast cancer. Women who used this type of hormone therapy for 15 years to about 20 years had a 43 percent increased risk. The risk of death from breast cancer did not appear to increase. Investigators are continuing to research this particular finding.

Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the Breast Cancer CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In